Share Market LIVE: Sensex, Nifty may open with gains; Pfizer, BioNtech’s covid-19 vaccine news lifts spirits

By: |
Updated: November 10, 2020 8:25:31 am

Share Market News Today | Sensex, Nifty, Share Prices LIVE: Now on a six-day gaining streak, Sensex and Nifty may look to make it seven days today with positive news flow of the coronavirus vaccine.

Share Market Today, Share Market LiveAsian markets were mirroring global trends on Tuesday morning, with Hang Seng up over 1%, followed by Japanese equity markets.

Share Market News Today | Sensex, Nifty, Share Prices LIVE: Domestic benchmark indices climbed to their all-time highs on Monday after the uncertainty around US Presidential Elections came to an end. S&P BSE Sensex closed at 42,597 points while the 50-stock NSE Nifty finished at 12,461 levels. Now on a six-day gaining streak, Sensex and Nifty may look to make it seven days today with positive news flow of the coronavirus vaccine. Asian markets were mirroring global trends on Tuesday morning, with Hang Seng up over 1%, followed by Japanese equity markets. Shanghai Composite and KOSDAQ were trading in the red.

On Monday, Pfizer and BioNtech said that a vaccine prepared by them for the coronavirus prevented more than 90% of infections in a study of tens of thousands of volunteers. The news was well received across the globe. Although the trial data will need to be studied by experts and reviewed by peers, initial results seem positive. If all goes well the vaccine could still take months to be delivered across the globe. However, the positive news flow has given bulls a good enough reason to take indices higher. 

Read More

Live Blog

Highlights

    08:25 (IST)10 Nov 2020
    Put option data

    November series is seeing maximum Put OI at 12,000 strike with 27.35 lakh contracts. 11,500 strike carries 25.01 lakh contracts.

    08:18 (IST)10 Nov 2020
    Call option data

    For the November series, maximum call option Open Interest (OI) is placed at 13,000 strike with 18.45 lakh contracts, followed by 12,500 strike with 15.34 lakh contracts.

    08:15 (IST)10 Nov 2020
    ITC Rating ‘Buy’; FMCG-Others business drove sales beat

    ITC’s standalone net sales were up 0.9% y-o-y, while Ebitda/PAT declined by 11%/19.7% y-o-y, respectively. Sales were 7.6% ahead of consensus, while Ebitda/PAT were largely in line with consensus expectations. This strong revenue beat was largely driven by the strong underlying performance of the FMCG-Others business, which grew by 18% y-o-y on a comparable basis and delivered significant margin expansion, leading to 66% segment Ebitda growth, which in our view is the key highlight of the result.

    Read full story

    08:11 (IST)10 Nov 2020
    Domestic markets also watching Bihar Elections

    Domestic investors will also keep eyes on the crucial Bihar election results today. Exit polls give the RJD led alliance an edge. "Exit polls indicate the possibility of hung assembly in Bihar. This is bit sentimental negative for the markets. We should watch out for Spirit (liquor cos) as there is a possibility of lifting the ban in the state if there is a non NDA Chief Minister," said Hemang Jani, Head – Equity Strategist, Motilal Oswal Financial Services.

    08:08 (IST)10 Nov 2020
    What have Pfizer and BioNtech said?

    • Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis.
    • Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected.
    • Submission for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) planned for soon after the required safety milestone is achieved, which is currently expected to occur in the third week of November.
    • Clinical trial to continue through to final analysis at 164 confirmed cases in order to collect further data and characterize the vaccine candidate’s performance against other study endpoints.

    08:06 (IST)10 Nov 2020
    Stocks surge to all-time high as Pfizer announces coronavirus vaccine; Stoxx Europe 600 Index rises 4.5%

    The clearest sign yet of progress on a Covid-19 vaccine is fueling a rally across global stock markets. A vaccine being developed by Pfizer Inc. and BioNTech SE prevented more than 90% of infections in a study of tens of thousands of volunteers. The preliminary findings surprised scientists about the possible effectiveness of a vaccine and fueled speculation among investors that there could be a path out of the pandemic. The strongest gains in the market were among small-cap stocks, which have been hit hard by the economic toll of lockdowns. Futures on the Russell 2000 Index of small-cap stocks jumped 7% and S&P 500 contracts rose 4.2%. Nasdaq 100 Index futures pared gains, but were still up 0.5%.

    Read full story

    Share Market Today | Sensex, Nifty, BSE, NSE, Share Prices, Stock Market News Live Updates
    Next Stories
    1Stocks in focus: GAIL, Hindalco, Ashok Leyland, Coal India, Tata Steel, TCS, Emami, pharma stocks
    2Lifetime highs: Markets on fire as recovery gains pace
    3ITC Rating ‘Buy’; FMCG-Others business drove sales beat